Generic Portal

— Research Explorer

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1016/j.eclinm.2022.101810
Final published version

InCHEHC study group
Daniela K. van Santen
Rachel Sacks-Davis
Ashleigh Stewart
Anders Boyd
Jim Young
Marc van der Valk
Colette Smit
Andri Rauch
Dominique L. Braun
Inmaculada Jarrin
Juan Berenguer
Jeffrey V. Lazarus
Karine Lacombe
Maria Bernarda Requena
Linda Wittkop
Olivier Leleux
Dominique Salmon
Fabrice Bonnet
Gail Matthews
Joseph S. Doyle
Tim Spelman
Marina B. Klein
Maria Prins
Jason Asselin
Mark A. Stoové
Margaret Hellard

Original language	English
Article number	101810
Journal	EClinicalMedicine
Volume	56
DOIs	https://doi.org/10.1016/j.eclinm.2022.101810
Publication status	Published - Feb 2023

Research areas

Direct-acting antivirals, Elimination, Hepatitis C virus, HIV, Incidence, Trends

ID: 30455768